Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

2.

Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.

Gupta N, Garg S, Vedi S, Kunimoto DY, Kumar R, Agrawal B.

Front Immunol. 2018 Oct 16;9:2371. doi: 10.3389/fimmu.2018.02371. eCollection 2018.

3.

Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.

Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J; SCORE2 Investigator Group.

JAMA. 2017 May 23;317(20):2072-2087. doi: 10.1001/jama.2017.4568.

4.

Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.

Gupta N, Vedi S, Kunimoto DY, Agrawal B, Kumar R.

Vaccine. 2016 Nov 4;34(46):5677-5688. doi: 10.1016/j.vaccine.2016.08.075. Epub 2016 Sep 29.

PMID:
27693020
5.

Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.

Garg S, Shakya N, Srivastav NC, Agrawal B, Kunimoto DY, Kumar R.

Bioorg Med Chem. 2016 Nov 1;24(21):5521-5533. doi: 10.1016/j.bmc.2016.09.008. Epub 2016 Sep 12.

PMID:
27665179
6.

Changing epidemiology of tuberculosis detected by an 8-year retrospective laboratory study in a tertiary teaching hospital in central Saudi Arabia.

Somily AM, Naeem T, Habib HA, Sarwar MS, Kunimoto DY, Kambal AM.

Saudi Med J. 2014 Jul;35(7):691-8.

PMID:
25028225
7.

Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.

Shakya N, Srivastav NC, Bhavanam S, Tse C, Desroches N, Agrawal B, Kunimoto DY, Kumar R.

Bioorg Med Chem. 2012 Jul 1;20(13):4088-97. doi: 10.1016/j.bmc.2012.05.004. Epub 2012 May 15.

PMID:
22664188
8.

Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.

Srivastav NC, Shakya N, Bhavanam S, Agrawal A, Tse C, Desroches N, Kunimoto DY, Kumar R.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1091-4. doi: 10.1016/j.bmcl.2011.11.114. Epub 2011 Dec 4.

PMID:
22178557
9.

Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.

Srivastav NC, Rai D, Tse C, Agrawal B, Kunimoto DY, Kumar R.

J Med Chem. 2010 Aug 26;53(16):6180-7. doi: 10.1021/jm100568q.

PMID:
20718497
10.

3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.

Shakya N, Srivastav NC, Desroches N, Agrawal B, Kunimoto DY, Kumar R.

J Med Chem. 2010 May 27;53(10):4130-40. doi: 10.1021/jm100165w.

PMID:
20420370
11.

Acute multifocal posterior placoid pigment epitheliopathy (AMPPPE) mimicking migraine with aura.

Spencer BR Jr, Kunimoto DY, Patel DR, Dodick DW.

Cephalalgia. 2009 Jun;29(6):694-8. doi: 10.1111/j.1468-2982.2008.01797.x. Epub 2009 Feb 10. No abstract available.

PMID:
19220303
12.

Metallic intraocular foreign bodies: characteristics, interventions, and prognostic factors for visual outcome and globe survival.

Ehlers JP, Kunimoto DY, Ittoop S, Maguire JI, Ho AC, Regillo CD.

Am J Ophthalmol. 2008 Sep;146(3):427-433. doi: 10.1016/j.ajo.2008.05.021. Epub 2008 Jul 9.

PMID:
18614135
13.

Incidence of endophthalmitis after 20- and 25-gauge vitrectomy.

Kunimoto DY, Kaiser RS; Wills Eye Retina Service.

Ophthalmology. 2007 Dec;114(12):2133-7. Epub 2007 Oct 4.

PMID:
17916378
14.

Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.

Rai D, Johar M, Srivastav NC, Manning T, Agrawal B, Kunimoto DY, Kumar R.

J Med Chem. 2007 Sep 20;50(19):4766-74. Epub 2007 Aug 16.

PMID:
17696514
15.

Candidemia complicated by endophthalmitis: a prospective analysis.

Kannangara S, Shindler D, Kunimoto DY, Sell B, DeSimone JA.

Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):839-41. No abstract available.

PMID:
17668252
16.
17.

Studies on acyclic pyrimidines as inhibitors of mycobacteria.

Srivastav NC, Manning T, Kunimoto DY, Kumar R.

Bioorg Med Chem. 2007 Mar 1;15(5):2045-53. Epub 2006 Dec 23.

PMID:
17218105
18.

Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates.

Chhabra S, Kunimoto DY, Kazi L, Regillo CD, Ho AC, Belmont J, Maguire J, Vander J, Brown GC.

Am J Ophthalmol. 2006 Nov;142(5):852-4.

PMID:
17056367
20.

Design and studies of novel 5-substituted alkynylpyrimidine nucleosides as potent inhibitors of mycobacteria.

Rai D, Johar M, Manning T, Agrawal B, Kunimoto DY, Kumar R.

J Med Chem. 2005 Nov 3;48(22):7012-7.

PMID:
16250660
21.

Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides.

Johar M, Manning T, Kunimoto DY, Kumar R.

Bioorg Med Chem. 2005 Dec 15;13(24):6663-71. Epub 2005 Sep 1.

PMID:
16140016
22.

Relationship between clinical presentation and visual outcome in postoperative and posttraumatic endophthalmitis in south central India.

Das T, Kunimoto DY, Sharma S, Jalali S, Majji AB, Nagaraja Rao T, Gopinathan U, Athmanathan S; Endophthalmitis Research Group.

Indian J Ophthalmol. 2005 Mar;53(1):5-16.

23.

Transplantation in the face of severe donor sepsis: pushing the boundaries?

Pauly RP, Rayner D, Murray AG, Gilmour SM, Kunimoto DY.

Am J Kidney Dis. 2004 Oct;44(4):e64-7.

PMID:
15384036
24.

Cataract extraction following penetrating keratoplasty.

Nagra PK, Rapuano CJ, Laibson PL, Kunimoto DY, Kay M, Cohen EJ.

Cornea. 2004 May;23(4):377-9.

PMID:
15097133
25.

Endophthalmitis after penetrating keratoplasty: microbiologic spectrum and susceptibility of isolates.

Kunimoto DY, Tasman W, Rapuano C, Recchia F, Busbee B, Pearlman R, Belmont J, Cohen E, Vander J, Laibson P, Raber I.

Am J Ophthalmol. 2004 Feb;137(2):343-5.

PMID:
14962427
26.

Analysis of Mycobacterium avium complex isolates from blood samples of AIDS patients by pulsed-field gel electrophoresis.

Kunimoto DY, Peppler MS, Talbot J, Phillips P, Shafran SD; Canadian HIV Trials Network Protocol 010 Study Group.

J Clin Microbiol. 2003 Jan;41(1):498-9.

27.
28.

Corneal ulceration in the elderly in Hyderabad, south India.

Kunimoto DY, Sharma S, Garg P, Gopinathan U, Miller D, Rao GN.

Br J Ophthalmol. 2000 Jan;84(1):54-9.

29.

IS1626, a new IS900-related Mycobacterium avium insertion sequence.

Puyang X, Lee K, Pawlichuk C, Kunimoto DY.

Microbiology. 1999 Nov;145 ( Pt 11):3163-3168. doi: 10.1099/00221287-145-11-3163.

PMID:
10589724
30.

Immune mediated 'HAART' attack during treatment for tuberculosis. Highly active antiretroviral therapy.

Kunimoto DY, Chui L, Nobert E, Houston S.

Int J Tuberc Lung Dis. 1999 Oct;3(10):944-7. Review.

PMID:
10524594
31.

Microbiologic spectrum and susceptibility of isolates: part II. Posttraumatic endophthalmitis. Endophthalmitis Research Group.

Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN.

Am J Ophthalmol. 1999 Aug;128(2):242-4.

PMID:
10458188
32.

Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group.

Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN.

Am J Ophthalmol. 1999 Aug;128(2):240-2.

PMID:
10458187
33.

In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.

Kunimoto DY, Sharma S, Garg P, Rao GN.

Ophthalmology. 1999 Jan;106(1):80-5.

PMID:
9917785
34.

Microbial keratitis in children.

Kunimoto DY, Sharma S, Reddy MK, Gopinathan U, Jyothi J, Miller D, Rao GN.

Ophthalmology. 1998 Feb;105(2):252-7.

PMID:
9479283
35.
36.

Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG.

Kong D, Kunimoto DY.

Infect Immun. 1995 Mar;63(3):799-803.

37.

Purification, crystallization and preliminary X-ray analysis of murine interleukin-5.

Boodhoo A, Duke NE, Kong D, Ritzel MW, Kunimoto DY, Read RJ.

J Mol Biol. 1994 Aug 12;241(2):269-72.

PMID:
8057365
38.

Molecular analysis of double isotype expression in IgA switching.

Kunimoto DY, Sneller MC, Claflin L, Mushinski JF, Strober W.

J Immunol. 1993 Feb 15;150(4):1338-47.

PMID:
8432981
39.

The roles of IL-4, TGF-beta and LPS in IgA switching.

Kunimoto DY, Ritzel M, Tsang M.

Eur Cytokine Netw. 1992 Jul-Aug;3(4):407-15.

PMID:
1421013
40.
41.
42.

Transforming growth factor-beta in a model of IgA switching.

Kunimoto DY.

Immunol Res. 1991;10(3-4):400-3. No abstract available.

PMID:
1955765
43.

IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis.

Kunimoto DY, Nordan RP, Strober W.

J Immunol. 1989 Oct 1;143(7):2230-5.

PMID:
2789259
44.

IgA B cell differentiation.

Harriman GR, Kunimoto DY, Strober W.

Immunol Invest. 1989 Jan-May;18(1-4):17-28. No abstract available.

PMID:
2786498
46.

Treating chancroid with enoxacin.

Naamara W, Kunimoto DY, D'Costa LJ, Ndinya-Achola JO, Nsanze H, Ronald AR, Plummer FA.

Genitourin Med. 1988 Jun;64(3):189-92.

47.

The role of IL-5 in IgA B cell differentiation.

Harriman GR, Kunimoto DY, Elliott JF, Paetkau V, Strober W.

J Immunol. 1988 May 1;140(9):3033-9.

PMID:
3258891
48.

Molecular analysis of membrane gamma 2b heavy chain expression.

Sneller MC, Kunimoto DY, Mushinski JF, Strober W.

Mol Immunol. 1988 Apr;25(4):393-401.

PMID:
2899838
49.

Urethral infection with Haemophilus ducreyi in men.

Kunimoto DY, Plummer FA, Namaara W, D'Costa LJ, Ndinya-Achola JO, Ronald AR.

Sex Transm Dis. 1988 Jan-Mar;15(1):37-9.

PMID:
3258676
50.

Molecular aspects of T cell regulation of B cell isotype differentiation.

Sneller MC, Kunimoto DY, Strober W.

Adv Exp Med Biol. 1987;216A:31-7. No abstract available.

PMID:
3120496

Supplemental Content

Loading ...
Support Center